Research on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining

Launched by TIANJIN MEDICAL UNIVERSITY GENERAL HOSPITAL · Aug 10, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how to better evaluate the vaginal microbiota, which refers to the balance of bacteria in the vagina, in women experiencing vaginal infections. The aim is to create a standardized method for collecting samples that will help doctors get more accurate results using a technique called Gram staining. This method helps to see the types of bacteria present and determine if there is an infection.

To participate in this study, you need to be a non-pregnant woman aged between 18 and 49 who has not had any sexual intercourse, used vaginal products, or taken any vaginal medications in the last three days. You should also not be on your period (meaning your menstruation should have stopped at least three days ago) and not have received any antifungal or antibiotic treatments in the past week. If you join the trial, you can expect to provide a vaginal discharge sample for testing, which will help improve future evaluations for vaginal infections. This study is not yet recruiting participants, but it aims to contribute valuable information to better understand and treat vaginal health issues.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Non-pregnant women who visit our research settings and conduct vaginal discharge examination based on Gram-stained smear.
• • No sexual intercourse, vaginal douching, or vaginal medication within the last 72 hours.
• • Not during menstruation (menstrual period ended ≥3 days ago).
• exclusion Criteria:
• • Receiving systemic or vaginal antifungal or antibiotic treatment within the past week.